-
1
-
-
0035806335
-
Development of a novel dosage form for intramuscular injection of titrated extract of Centella asiatica in a mixed micellar system
-
C. Kim, Y. Y. Hwang, J. Y. Chang, H. G. Choi, S. J. Lim, and M. K. Lee. Development of a novel dosage form for intramuscular injection of titrated extract of Centella asiatica in a mixed micellar system. Int. J. Pharm. 220:141-147 (2001).
-
(2001)
Int. J. Pharm.
, vol.220
, pp. 141-147
-
-
Kim, C.1
Hwang, Y.Y.2
Chang, J.Y.3
Choi, H.G.4
Lim, S.J.5
Lee, M.K.6
-
2
-
-
0024343540
-
Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities
-
A. Yoshida, M. Yamamoto, T. Irie, F. Hirayama, and K. Uekama. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities. Chem. Pharm. Bull. (Tokyo). 37:1059-1063 (1989).
-
(1989)
Chem. Pharm. Bull. (Tokyo).
, vol.37
, pp. 1059-1063
-
-
Yoshida, A.1
Yamamoto, M.2
Irie, T.3
Hirayama, F.4
Uekama, K.5
-
3
-
-
0345095318
-
Intravenous drug preparation practices: A survey in a French university hospital
-
P. Tilleul, B. Mons, C. Schmitt, J. M. Laporte, and D. Begue. Intravenous drug preparation practices: A survey in a French university hospital. Pharm. World Sci. 25:276-279 (2003).
-
(2003)
Pharm. World Sci.
, vol.25
, pp. 276-279
-
-
Tilleul, P.1
Mons, B.2
Schmitt, C.3
Laporte, J.M.4
Begue, D.5
-
4
-
-
84891936275
-
Solubilization using cosolvent approach
-
Liu IR, (eds.) Interpharm, Denver, Colorado
-
J. S. Trivedi, and M. L. Wells. Solubilization using cosolvent approach. Liu IR, (eds.), Water-Insoluble Drug Formulation, Interpharm, Denver, Colorado, 2000, pp. 141-168.
-
(2000)
Water-Insoluble Drug Formulation
, pp. 141-168
-
-
Trivedi, J.S.1
Wells, M.L.2
-
5
-
-
1242337285
-
Solubilizing excipients in oral and injectable formulations
-
R. G. Strickley. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21:201-230 (2004).
-
(2004)
Pharm. Res.
, vol.21
, pp. 201-230
-
-
Strickley, R.G.1
-
6
-
-
23144465464
-
Solubility enhancement of Cox-2 inhibitors using various solvent systems
-
N. Seedher, and S. Bhatia. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS PharmSciTech. 4:E33 (2003).
-
(2003)
AAPS PharmSciTech
, vol.4
-
-
Seedher, N.1
Bhatia, S.2
-
7
-
-
0037220089
-
Differential analgesic effect of tenoxicam on the wound pain and uterine cramping pain after cesarean section
-
H. W. Hsu, Y. J. Cheng, L. K. Chen, Y. P. Wang, C. J. Lin, C. N. Lee, and W. Z. Sun. Differential analgesic effect of tenoxicam on the wound pain and uterine cramping pain after cesarean section. Clin. J. Pain. 19:55-58 (2003).
-
(2003)
Clin. J. Pain.
, vol.19
, pp. 55-58
-
-
Hsu, H.W.1
Cheng, Y.J.2
Chen, L.K.3
Wang, Y.P.4
Lin, C.J.5
Lee, C.N.6
Sun, W.Z.7
-
8
-
-
0028935760
-
Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography
-
J. L. Mason, and G. J. Hobbs. Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 65:410-415 (1995).
-
(1995)
J. Chromatogr. B Biomed. Appl.
, vol.65
, pp. 410-415
-
-
Mason, J.L.1
Hobbs, G.J.2
-
9
-
-
0036667948
-
Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel
-
W. J. Loos, J. Szebeni, A. J. ten Tije, J. Verweij, D. M. van Zomeren, K. N. Chung, K. Nooter, G. Stoter, and A. Sparreboom. Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel. Anticancer Drugs. 3:767-775 (2002).
-
(2002)
Anticancer Drugs.
, vol.3
, pp. 767-775
-
-
Loos, W.J.1
Szebeni, J.2
ten Tije, A.J.3
Verweij, J.4
van Zomeren, D.M.5
Chung, K.N.6
Nooter, K.7
Stoter, G.8
Sparreboom, A.9
-
10
-
-
0344515259
-
In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/ mass spectrometry detection
-
H. Liu, C. Sabus, G. T. Carter, C. Du, A. Avdeef, and M. Tischler. In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection. Pharm. Res. 20:1820-1826 (2003).
-
(2003)
Pharm. Res.
, vol.20
, pp. 1820-1826
-
-
Liu, H.1
Sabus, C.2
Carter, G.T.3
Du, C.4
Avdeef, A.5
Tischler, M.6
-
11
-
-
1842609789
-
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs
-
B. K. Kang, J. S. Lee, S. K. Chon, S. Y. Jeong, S. H. Yuk, G. Khang, H. B. Lee, and S. H. Cho. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 274:65-73 (2004).
-
(2004)
Int. J. Pharm.
, vol.274
, pp. 65-73
-
-
Kang, B.K.1
Lee, J.S.2
Chon, S.K.3
Jeong, S.Y.4
Yuk, S.H.5
Khang, G.6
Lee, H.B.7
Cho, S.H.8
-
12
-
-
0032749686
-
Formulation development of allopurinol suppositories and injectables
-
D. K. Lee, and D. P. Wang. Formulation development of allopurinol suppositories and injectables. Drug Dev. Ind. Pharm. 25:1205-1208 (1999).
-
(1999)
Drug Dev. Ind. Pharm.
, vol.25
, pp. 1205-1208
-
-
Lee, D.K.1
Wang, D.P.2
-
13
-
-
0037413385
-
Enhanced transport of a novel anti-HIV agent-cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers
-
C. Udata, J. Patel, D. Pal, E. Hejchman, M. Cushman, and A. K. Mitra. Enhanced transport of a novel anti-HIV agent-cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. Int. J. Pharm. 250:157-168 (2003).
-
(2003)
Int. J. Pharm.
, vol.250
, pp. 157-168
-
-
Udata, C.1
Patel, J.2
Pal, D.3
Hejchman, E.4
Cushman, M.5
Mitra, A.K.6
-
14
-
-
2642542630
-
Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent
-
K. Kawakami, K. Miyoshi, and Y. Ida. Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent. J. Pharm. Sci. 93:1471-1479 (2004).
-
(2004)
J. Pharm. Sci.
, vol.93
, pp. 1471-1479
-
-
Kawakami, K.1
Miyoshi, K.2
Ida, Y.3
-
15
-
-
0027291815
-
Bioavailability of intramuscularly administered tenoxicam
-
T. Stebler, and T. W. Guentert. Bioavailability of intramuscularly administered tenoxicam. Biopharm. Drug Dispos. 14:483-490 (1993).
-
(1993)
Biopharm. Drug Dispos.
, vol.14
, pp. 483-490
-
-
Stebler, T.1
Guentert, T.W.2
-
16
-
-
0037242323
-
Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel
-
D. Chen, D. Song, M. G. Wientjes, and J. L. Au. Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel. Clin. Cancer Res. 9:363-369 (2003).
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 363-369
-
-
Chen, D.1
Song, D.2
Wientjes, M.G.3
Au, J.L.4
-
17
-
-
0029068063
-
Use of a water-soluble busulfan formulation-pharmacokinetic studies in a canine model
-
G. Ehninger, U. Schuler, U. Renner, M. Ehrsam, K. P. Zeller, J. Blanz, R. Storb, and H. Deeg. Use of a water-soluble busulfan formulation-pharmacokinetic studies in a canine model. Blood. 85:3247-3249 (1995).
-
(1995)
Blood
, vol.85
, pp. 3247-3249
-
-
Ehninger, G.1
Schuler, U.2
Renner, U.3
Ehrsam, M.4
Zeller, K.P.5
Blanz, J.6
Storb, R.7
Deeg, H.8
-
18
-
-
0031682636
-
Pharmacokinetics and distribution of liposomal busulfan in the rat: A new formulation for intravenous administration
-
M. Hassan, Z. Hassan, C. Nilsson, M. A. Rehim, S. Kumlien, B. Elfsson, and N. Kallberg. Pharmacokinetics and distribution of liposomal busulfan in the rat: A new formulation for intravenous administration. Cancer. Chemother. Pharmacol. 42:471-478 (1998).
-
(1998)
Cancer. Chemother. Pharmacol.
, vol.42
, pp. 471-478
-
-
Hassan, M.1
Hassan, Z.2
Nilsson, C.3
Rehim, M.A.4
Kumlien, S.5
Elfsson, B.6
Kallberg, N.7
-
19
-
-
0031854708
-
Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation
-
U. S. Schuler, M. Ehrsam, A. Schneider, H. Schmidt, J. Deeg, and G. Ehninger. Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation. Bone Marrow Transplant. 22:241-244 (1998).
-
(1998)
Bone Marrow Transplant
, vol.22
, pp. 241-244
-
-
Schuler, U.S.1
Ehrsam, M.2
Schneider, A.3
Schmidt, H.4
Deeg, J.5
Ehninger, G.6
|